DE BORTOLI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 17.590
AS - Asia 8.262
EU - Europa 5.484
SA - Sud America 1.500
Continente sconosciuto - Info sul continente non disponibili 622
AF - Africa 335
OC - Oceania 32
Totale 33.825
Nazione #
US - Stati Uniti d'America 17.081
SG - Singapore 2.810
IT - Italia 2.078
CN - Cina 2.060
HK - Hong Kong 1.333
BR - Brasile 1.180
VN - Vietnam 784
SE - Svezia 610
DE - Germania 505
GB - Regno Unito 422
BG - Bulgaria 389
FR - Francia 313
CA - Canada 311
FI - Finlandia 295
IN - India 223
RU - Federazione Russa 204
TR - Turchia 176
KR - Corea 169
JP - Giappone 153
AT - Austria 135
BD - Bangladesh 120
AR - Argentina 113
UA - Ucraina 104
CI - Costa d'Avorio 93
NL - Olanda 93
MX - Messico 81
PL - Polonia 74
ID - Indonesia 66
IQ - Iraq 62
ZA - Sudafrica 58
ES - Italia 55
CH - Svizzera 54
EC - Ecuador 42
PK - Pakistan 41
BE - Belgio 35
SA - Arabia Saudita 35
CO - Colombia 34
MA - Marocco 32
VE - Venezuela 32
UZ - Uzbekistan 29
AU - Australia 28
SN - Senegal 28
CL - Cile 26
NG - Nigeria 26
IR - Iran 24
EG - Egitto 22
JM - Giamaica 22
PY - Paraguay 22
MY - Malesia 21
PE - Perù 21
UY - Uruguay 20
JO - Giordania 19
PH - Filippine 19
CR - Costa Rica 18
LT - Lituania 18
PT - Portogallo 17
KE - Kenya 16
TN - Tunisia 16
NO - Norvegia 15
CZ - Repubblica Ceca 14
DZ - Algeria 14
IL - Israele 14
NI - Nicaragua 13
TH - Thailandia 13
AZ - Azerbaigian 11
NP - Nepal 11
TT - Trinidad e Tobago 11
AE - Emirati Arabi Uniti 10
PA - Panama 10
DO - Repubblica Dominicana 9
LB - Libano 9
BO - Bolivia 8
ET - Etiopia 8
OM - Oman 8
AL - Albania 7
GR - Grecia 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
EU - Europa 6
HN - Honduras 6
IE - Irlanda 6
KG - Kirghizistan 6
BB - Barbados 5
DK - Danimarca 5
GT - Guatemala 5
SV - El Salvador 5
HU - Ungheria 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BJ - Benin 3
BS - Bahamas 3
GA - Gabon 3
GE - Georgia 3
KH - Cambogia 3
PS - Palestinian Territory 3
QA - Qatar 3
AO - Angola 2
Totale 33.166
Città #
Ashburn 1.859
Singapore 1.527
Hong Kong 1.307
Fairfield 1.097
San Jose 1.068
Woodbridge 1.035
Santa Clara 914
Houston 808
Dallas 796
Ann Arbor 759
Chandler 616
Seattle 498
Shanghai 490
Serra 457
Milan 421
Cambridge 396
Sofia 388
Council Bluffs 387
Wilmington 387
Beijing 382
New York 376
Boardman 296
Los Angeles 277
Hefei 221
Ho Chi Minh City 206
Princeton 184
London 183
Ottawa 173
Lauterbourg 160
Seoul 158
Lawrence 153
Medford 146
Helsinki 140
Hanoi 135
Tokyo 132
Munich 117
Jacksonville 110
São Paulo 103
Vienna 103
Florence 99
Nanjing 99
Dong Ket 94
Abidjan 93
Des Moines 90
Buffalo 89
Redondo Beach 87
Atlanta 86
Dearborn 85
Istanbul 75
Frankfurt am Main 74
Lucca 74
Rome 69
Pisa 63
Izmir 62
San Diego 62
Orem 59
Phoenix 59
Chicago 55
Redwood City 47
Washington 46
Bern 43
Warsaw 43
Denver 42
Nuremberg 42
Turku 42
Brooklyn 41
Nanchang 41
Toronto 38
Chennai 37
Haiphong 36
Hyderabad 36
San Francisco 36
Belo Horizonte 35
Brussels 32
Düsseldorf 30
Montreal 30
Ogden 30
Changsha 29
Falls Church 29
Tashkent 29
Dakar 28
Rio de Janeiro 28
Johannesburg 27
Amsterdam 26
Fuzhou 26
Shenyang 26
Baghdad 25
Lagos 25
Lancaster 25
Dhaka 24
Kunming 24
Guangzhou 23
Brasília 22
Bremen 22
Da Nang 21
Falkenstein 21
Manchester 21
Paris 21
Stockholm 21
Curitiba 20
Totale 21.729
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 578
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 508
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 347
Abnormal Milan Score and Compromised Esophageal Mucosal Integrity Stratify Gastroesophageal Reflux Disease Severity 302
Management of Chronic constipation in general practice 276
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 268
Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG) 266
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 260
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 260
Efficacy of Dupilumab for Induction and Maintenance of Remission in Patients With Eosinophilic Gastritis, Enteritis, and Colitis With Concomitant Eosinophilic Esophagitis 255
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 243
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 239
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 237
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 237
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 232
Effectiveness and Safety of Orodispersible Budesonide for Eosinophilic Esophagitis: A Multicenter Real-World Study 231
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 230
The Revised Reflux Symptom Index (R-RSI): Development, Internal and External Validation Study 226
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 225
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 221
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 216
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 216
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 215
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 209
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 208
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 203
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 202
Low FODMAP diet: Evidence, doubts, and hopes 201
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 200
Irritable bowel syndrome and chronic constipation: Fact and fiction 196
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 195
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 193
Management of chronic constipation in general practice. 192
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 192
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 191
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 190
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 189
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 186
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 186
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 185
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 183
Eating habits trajectories of students using university canteens 183
Presbifagia Esofagea 183
Refractory Gastroesophageal Reflux Disease: A Management Update 183
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 182
Radionuclide evaluation of the lower gastrointestinal tract 181
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 180
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 180
Barrett's esophagus in 2016: From pathophysiology to treatment 179
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 178
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 178
Esophageal motility abnormalities in gastroesophageal reflux disease 177
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 177
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 176
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 176
Updates in the field of non-esophageal gastroesophageal reflux disorder 176
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 174
Vonoprazan fumarate for the management of acid-related diseases 174
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 173
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 173
Letter: Peripheral Blood Eosinophils as Complementary Biomarkers for Diagnosis and Follow‐Up in Eosinophilic Oesophagitis—Authors' Reply 172
Esophageal testing: What we have so far 171
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 170
Advancements in the use of manometry and impedance testing for esophageal functional disorders 170
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 169
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 169
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 169
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 168
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 168
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 168
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 166
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 166
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 165
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 164
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 164
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 163
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 162
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 162
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 162
Evaluation of latent links between irritable bowel syndrome and sleep quality 161
The natural history of gastro-esophageal reflux disease: A comprehensive review 161
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 161
Gastrointestinal involvement in systemic sclerosis 158
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 158
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 158
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 158
Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0© 157
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 156
High Resolution and High Definition Anorectal Manometry 156
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 156
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 155
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 155
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 155
Current and future perspectives in the management of gastroesophageal reflux disease 155
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 154
Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS 153
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 152
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 152
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 152
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 151
Totale 19.614
Categoria #
all - tutte 98.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.559 0 0 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.849 183 183 235 168 226 310 91 57 45 50 81 220
2024/20257.009 85 237 187 388 564 721 531 374 751 888 846 1.437
2025/20269.789 682 1.118 1.086 1.013 924 764 1.287 518 649 1.023 438 287
2026/20273.273 905 1.470 898 0 0 0 0 0 0 0 0 0
Totale 33.825